ChemWerth
-
ChemWerth to Rebuild Quality Systems for Chinese Pharma Company
Xi’An Libang Pharmaceutical, Xi’An, China, has appointed ChemWerth as their consultant for the purpose of responding to an US Food and Drug Administration (FDA) warning letter. Jeffery Hangartner, a former FDA investigator who now heads a reg…
ChemWerth | 17 March 2010
-
ChemWerth: Chinese Partner Factory Passes FDA Inspection
ChemWerth has announced that its partner, JiangXi Guo Yao (Guo Yao) pharmaceutical facility has passed an US Food and Drug Administration (FDA) overseas inspection. Guo Yao’s main products exported to the US include Lincomycin HCl and Oxytetracy…
ChemWerth | 16 October 2009
-
API: The Right Choice
What drug manufacturers need to know, when selecting an Active Pharmaceutical Ingredient (API) supplier
ChemWerth | 01 October 2009
-
ChemWerth Partners with Steroid API Manufacturer
ChemWerth has announced a manufacturing partnership with Tianjin Tianyao Pharmaceuticals, a manufacturer of corticosteroid products in Asia. Located in Tianjin, China, the latter holds the chairmanship of the Chinese state steroid hormone association…
ChemWerth | 25 May 2009
